In poor countries and communities, it is a common saying that “cancer is a sickness only for the rich,” but little do most people realize is that this phrase is far from the truth, in fact, it is almost the opposite. The sad reality is that this sentence is borne out of lack of information, especially in poor communities. The truth is, cancer is one of the deadliest diseases in the world, and it can hit anyone at any time, painfully, when you least expect it, as there are many types of cancer and many different sources that can increase your chances of getting the disease. Cancer doesn’t care whether you are rich or poor, young or old, fit or unhealthy. It hits people like a thief in the night, and it is still one of those diseases where treatment is often unaffordable and inconclusive.
The research and the run for the cure for cancer, thankfully, is one of the most studied topics in Medicine, and this is where the work of Mikhail Blagosklonny comes in. Know more about Mikhail at Philly Purge.
Mikhail Blagosklonny is one of the world’s top oncologists and has spent his life researching treatment methods and cures for cancer that would both be effective and affordable for the masses. Mikhail’s research on what is now considered ‘wonder drug’ Rapamycin has achieved prominence over the years.
In many cases of cancer, an organ transplant is needed, but the body’s immune system’s response is always to ‘defeat’ foreign substances. With that, when an organ transplant is done, the immunity system’s response would be to fight off the organ that came from somebody else. It is tough to achieve these transplants without the help of something that will convince the body to accept the new organ, and that is where this wonder drug, Rapamycin comes in, developed by Mikhail Blagosklonny himself. Rapamycin is an immuno-suppressant drug, which means it can deny the rejection of the immunity system, that can prevent this kind of ‘organ rejection’ by the body. Read Mikhail’s plans for Oncology on Healingmagic.net.
Rapamycin’s use is not limited to organ transplants. It is also recognized as a very effective anti-proliferative drug. This means that it stops cancer cells from proliferating throughout the body, thus preventing the growth of cancer towards other organs. Aside from this, Rapamycin is the drug of choice for the treatment of Lymphangioleiomyomatosis.
Mikhail Blagosklonny believes that more profound research about Rapamycin can uncover its full potential and it will lead to more efficient and affordable ways of treating cancer.